Neupro 8mg/24h Patches / Transdermal

Rotigotine
18mg
UCB MANUFACTURING IRELAND LTD.
Pack size 28 Patches
Dispensing mode POM
Source IRELAND
AgentModern Pharmaceutical Co.
Retail Price 828.50 AED

Indications

Neupro 8mg/24h Patches / Transdermal is used for: For use/treatment in neurologic disorders and parkinson's disease as well as moderate-to-severe primary restless legs syndrome

Adult Dose

Child Dose

Renal Dose

Administration

Contra Indications

Precautions

Pregnancy-Lactation

Interactions

Adverse Effects

Side effects of Rotigotine :

Mechanism of Action

Rotigotine, a member of the dopamine agonist class of drugs, is delivered continuously through the skin (transdermal) using a silicone-based patch that is replaced every 24 hours. A dopamine agonist works by activating dopamine receptors in the body, mimicking the effect of the neurotransmitter dopamine. The precise mechanism of action of rotigotine as a treatment for restless legs syndrome is unknown but is thought to be related to its ability to stimulate dopamine

Note

Neupro 8mg/24h 18mg Patches / Transdermal manufactured by UCB MANUFACTURING IRELAND LTD.. Its generic name is Rotigotine. Neupro 8mg/24h is availble in United Arab Emirates. Farmaco UAE drug index information on Neupro 8mg/24h Patches / Transdermal is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Rotigotine :